Funding · Company
CeleCor Therapeutics, Inc.
Del Mar, CABiotech & Pharma
CeleCor Therapeutics, Inc. of Del Mar, CA has disclosed $46M across 1 Form D offering filed with the SEC on Aug 21, 2024.
$46M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$46M
Form D · Aug 21, 2024 ↗
Q3 2024
· 2 amendments, first filed Mar 8, 2022
Filing details
HeadquartersDel Mar, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001705381Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →